Zimmer Biomet Holdings (ZBH) said Monday it has completed its acquisition of medical device company Paragon 28.
Each Paragon 28 share was converted into the right to get $13 in cash and a non-tradeable contingent value right entitling holders to receive cash of up to $1 per share if certain revenue milestones are met, Zimmer Biomet said.
The company said shares of Paragon 28, which is now its wholly owned unit, ceased trading on the New York Stock Exchange before the market opened on Monday and will be delisted.
Price: 94.39, Change: -3.54, Percent Change: -3.61
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。